Bax Inhibitor 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| BAX Inhibitor 1 | |
|---|---|
| Gene Symbol | TMBIM6 |
| Full Name | Transmembrane BAX Inhibitor Motif Containing 6 |
| Chromosome | 12q13.12 |
| NCBI Gene ID | 7099 |
| OMIM | 600947 |
| Ensembl ID | ENSG00000125148 |
| UniProt ID | P55072 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Stroke |
TMBIM6 (Transmembrane BAX Inhibitor Motif Containing 6), also known as BAX Inhibitor 1 (BI1), is a highly conserved anti-apoptotic protein localized to the endoplasmic reticulum (ER) membrane. It was originally identified as a protein that suppresses BAX-induced cell death, hence its name.
In the brain, TMBIM6 plays critical roles in protecting neurons from various insults including amyloid-beta toxicity (Alzheimer's disease), α-synuclein toxicity (Parkinson's disease), and ischemic injury (stroke). It exerts its neuroprotective effects through multiple mechanisms including ER calcium homeostasis regulation, modulation of ER stress responses, and maintenance of mitochondrial function.
TMBIM6 (formerly known as BI1 - BAX Inhibitor 1) encodes an ER-resident protein that protects cells from apoptosis by inhibiting BAX-induced cell death. It is a highly conserved protein across species and functions as an anti-apoptotic regulator by modulating calcium homeostasis, ER stress responses, and mitochondrial function.
TMBIM6 is widely expressed with high levels in brain. It localizes to the endoplasmic reticulum membrane.
| Disease | Mechanism | Evidence |
|---|---|---|
| Alzheimer's Disease | TMBIM6 deficiency worsens amyloid pathology | Mouse models |
| Parkinson's Disease | Protects dopaminergic neurons from mitochondrial toxins | TMBIM6 overexpression is protective |
| Stroke | TMBIM6 is neuroprotective in ischemic injury | Animal models |
The study of Bax Inhibitor 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.